Wolverine Trading’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Wolverine Trading’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,900	Closed	-$70K	–	7412
2021 Q2	$70K	Buy	+10,900	New	+$71.9K	﹤0.01%	5536
2020 Q1	–	Sell	-13,500	Closed	-$43K	–	5711
2019 Q4	$43K	Buy	+13,500	New	+$54.1K	﹤0.01%	4492
2017 Q3	–	Sell	-5,885	Closed	-$60K	–	5517
2017 Q2	$60K	Sell	5,885 -1,156	-16%	-$23.6K	﹤0.01%	4022
2017 Q1	$170K	Sell	7,041 -255	-3%	-$6.38K	﹤0.01%	3630
2016 Q4	$234K	Buy	7,296 +3,114	+74%	+$133K	﹤0.01%	3558
2016 Q3	$206K	Buy	4,182 +2,530	+153%	+$105K	﹤0.01%	3795
2016 Q2	$73K	Buy	+1,652	New	+$90K	﹤0.01%	3732

Other funds holding MACK

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $1.84B AUM 18.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wolverine Trading's MACK Position: Q2 2021 in Review

Wolverine Trading sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2021, closing a stake of 10,124 shares — an estimated $66.8K sold.

Wolverine Trading first reported a position in MACK in Q4 2016 and held it in 5 quarters. The position peaked at $91K in Q2 2018. 43 funds tracked by Wall St. Rank hold MACK as of Q2 2021.

Wolverine Trading reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Wolverine Trading sold 10,124 Merrimack Pharmaceuticals, Inc. shares in Q2 2021, an estimated $66.8K.
Wolverine Trading first reported a position in Merrimack Pharmaceuticals, Inc. in Q4 2016 and held it in 5 quarters.
Wolverine Trading's Merrimack Pharmaceuticals, Inc. position peaked at $91K in Q2 2018.
43 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.